Tim M Reynolds

Summary

Affiliation: Birmingham Heartlands Hospital
Country: UK

Publications

  1. pmc Down's syndrome screening: a controversial test, with more controversy to come!
    T M Reynolds
    Queen s Hospital and Division of Clinical Sciences, Wolverhampton University, Wolverhampton WV1 1SB, UK
    J Clin Pathol 53:893-8. 2000
  2. ncbi request reprint Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetes
    Timothy M Reynolds
    Queen s Hospital, Burton on Trent, Staffordshire and Division of Clinical Sciences, Wolverhampton University, UK
    J Cardiovasc Risk 9:183-90. 2002
  3. ncbi request reprint Hemoglobin Wayne in a British family: identification by electrospray ionization/mass spectrometry
    Tim M Reynolds
    Clinical Chemistry Department, Queen s Hospital, Belvedere Road, Burton on Trent, Staffordshire DE13 0RB, United Kingdom
    Clin Chem 48:2261-3. 2002
  4. pmc Does activity in research correlate with visibility?
    T M Reynolds
    Queen s Hospital, Belvedere Road, Burton on Trent, Staffordshire DE13 0RB, UK
    J Clin Pathol 57:426-7. 2004
  5. ncbi request reprint Randomized clinical trial comparing 2 support surfaces: results of the Prevention of Pressure Ulcers Study
    Linda J Russell
    Queen s Hospital, Burton on Trent, UK
    Adv Skin Wound Care 16:317-27. 2003
  6. pmc Implications of method specific creatinine adjustments on General Medical Services chronic kidney disease classification
    Timothy M Reynolds
    Department of Chemical Pathology, Queen s Hospital, Burton on Trent, UK
    J Clin Pathol 60:1048-50. 2007
  7. ncbi request reprint Can we manage demand for allergy testing by restricting requests to a small number of prime target allergens?
    Timothy M Reynolds
    Department of Chemical Pathology, Queen s Hospital, Burton on Trent, Staffordshire DE13 0RB, UK
    Ann Clin Biochem 44:467-70. 2007
  8. ncbi request reprint Concordance evaluation of coronary risk scores: implications for cardiovascular risk screening
    Timothy M Reynolds
    Consultant Chemical Pathologist, Queen s Hospital, Burton on Trent and Division of Clinical Sciences, Wolverhampton University, UK
    Curr Med Res Opin 20:811-8. 2004
  9. ncbi request reprint Targeted versus global approaches to the management of hypercholesterolaemia
    Timothy M Reynolds
    Clinical Chemistry Dept, Queen s Hospital, Belvedere Road, Burton on Trent, Staffordshire DE13 0RB, UK
    J R Soc Promot Health 128:248-54. 2008
  10. ncbi request reprint More on PROSPER
    Anthony S Wierzbicki
    Lancet 361:1135-6; author reply 1136. 2003

Collaborators

Detail Information

Publications21

  1. pmc Down's syndrome screening: a controversial test, with more controversy to come!
    T M Reynolds
    Queen s Hospital and Division of Clinical Sciences, Wolverhampton University, Wolverhampton WV1 1SB, UK
    J Clin Pathol 53:893-8. 2000
    ..Furthermore, if a national policy is decided upon, worldwide patent searches should be carried out to determine whether there are any possible unforeseen legal consequences of any recommendation...
  2. ncbi request reprint Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetes
    Timothy M Reynolds
    Queen s Hospital, Burton on Trent, Staffordshire and Division of Clinical Sciences, Wolverhampton University, UK
    J Cardiovasc Risk 9:183-90. 2002
    ..We investigated the effects of biological variation in risk factors on risk estimate accuracy and whether current primary prevention screening (risk assessment) models correctly categorize patients...
  3. ncbi request reprint Hemoglobin Wayne in a British family: identification by electrospray ionization/mass spectrometry
    Tim M Reynolds
    Clinical Chemistry Department, Queen s Hospital, Belvedere Road, Burton on Trent, Staffordshire DE13 0RB, United Kingdom
    Clin Chem 48:2261-3. 2002
  4. pmc Does activity in research correlate with visibility?
    T M Reynolds
    Queen s Hospital, Belvedere Road, Burton on Trent, Staffordshire DE13 0RB, UK
    J Clin Pathol 57:426-7. 2004
    ..It could be considered that published research that is not cited in other work is not useful unless it has achieved visibility, as demonstrated by citation in another research publication...
  5. ncbi request reprint Randomized clinical trial comparing 2 support surfaces: results of the Prevention of Pressure Ulcers Study
    Linda J Russell
    Queen s Hospital, Burton on Trent, UK
    Adv Skin Wound Care 16:317-27. 2003
    ..To determine whether a viscoelastic polymer (energy absorbing) foam mattress was superior to a standard hospital mattress for pressure ulcer prevention and to analyze the cost-effectiveness in comparison with standard hospital mattresses...
  6. pmc Implications of method specific creatinine adjustments on General Medical Services chronic kidney disease classification
    Timothy M Reynolds
    Department of Chemical Pathology, Queen s Hospital, Burton on Trent, UK
    J Clin Pathol 60:1048-50. 2007
    ..To evaluate the impact of different equations for calculation of estimated glomerular filtration rate (eGFR) on general practitioner (GP) workload...
  7. ncbi request reprint Can we manage demand for allergy testing by restricting requests to a small number of prime target allergens?
    Timothy M Reynolds
    Department of Chemical Pathology, Queen s Hospital, Burton on Trent, Staffordshire DE13 0RB, UK
    Ann Clin Biochem 44:467-70. 2007
    ..Different hospitals have different policies on allergen testing. We report a comparison of the effect of requesting policy on diagnostic yield...
  8. ncbi request reprint Concordance evaluation of coronary risk scores: implications for cardiovascular risk screening
    Timothy M Reynolds
    Consultant Chemical Pathologist, Queen s Hospital, Burton on Trent and Division of Clinical Sciences, Wolverhampton University, UK
    Curr Med Res Opin 20:811-8. 2004
    ..The predictive capacities of 3 different risk identification systems based on computer calculation (the Framingham algorithm), or on tabular methods (the Sheffield tables and the General Rule to Enable Atheroma Treatment) were evaluated...
  9. ncbi request reprint Targeted versus global approaches to the management of hypercholesterolaemia
    Timothy M Reynolds
    Clinical Chemistry Dept, Queen s Hospital, Belvedere Road, Burton on Trent, Staffordshire DE13 0RB, UK
    J R Soc Promot Health 128:248-54. 2008
    ..However, there is debate about the most effective approach to primary prevention. This study simulated the effects of directed versus global approaches for intervention on coronary heart disease (CHD) event rates...
  10. ncbi request reprint More on PROSPER
    Anthony S Wierzbicki
    Lancet 361:1135-6; author reply 1136. 2003
  11. ncbi request reprint Accuracy of cardiovascular risk estimation
    Timothy M Reynolds
    Clin Chem 49:706-7. 2003
  12. ncbi request reprint Cost utility of prenatal diagnosis
    Anthony S Wierzbicki
    Lancet 363:1165. 2004
  13. doi request reprint Non-ceruloplasmin-bound copper in routine clinical practice in different laboratories
    Patrick J Twomey
    Department of Clinical Biochemistry, The Ipswich Hospital, Ipswich IP4 5PD, UK
    J Trace Elem Med Biol 22:50-3. 2008
    ..Non-ceruloplasmin-bound copper is a calculated parameter devised for the investigation of patients who potentially have WD...
  14. ncbi request reprint Usefulness of Orlistat in the treatment of severe hypertriglyceridemia
    Anthony S Wierzbicki
    Department of Chemical Pathology, St Thomas Hospital, London, United Kingdom
    Am J Cardiol 89:229-31. 2002
  15. pmc Copper:caeruloplasmin ratio
    Patrick J Twomey
    Department of Clinical Biochemistry, The Ipswich Hospital, Ipswich, UK
    J Clin Pathol 60:441-2. 2007
    ..Caeruloplasmin assays also have uncertainty from precision, bias and specificity and, accordingly, method-related differences may have a large effect on the copper:caeruloplasmin ratio in a manner similar to the NCC...
  16. ncbi request reprint Prevalence of kidney disease and estimated GFR in routine practice
    Timothy M Reynolds
    Ann Clin Biochem 43:84-5; author reply 86-7. 2006
  17. ncbi request reprint Cardiovascular risk assessment
    Anthony S Wierzbicki
    Lancet 365:1305-6. 2005
  18. ncbi request reprint Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes
    Patrick J Twomey
    Diabetes Care 27:2569-70. 2004
  19. ncbi request reprint Screening for cardiovascular disease
    Anthony S Wierzbicki
    Eur Heart J 25:996; author reply 996-7. 2004
  20. ncbi request reprint Issues to consider when attempting to achieve the American Diabetes Association clinical quality requirement for haemoglobin A1c
    Patrick J Twomey
    Specialist Registrar in Clinical Biochemistry, Edinburgh Royal Infirmary, Edinburgh, UK
    Curr Med Res Opin 19:719-23. 2003
    ..Delta check' criteria ought to be applied and results reported to highlight acute deviations in A1C. Such procedures will aid the attainment of the clinical quality requirements and give appropriate results for audit purposes...
  21. ncbi request reprint Use of coronary calcification scores to predict coronary heart disease
    Anthony S Wierzbicki
    JAMA 291:1831; author reply 1832-3. 2004